文献速递乳腺癌

数字乳腺断层摄影与乳腺X线摄影人群筛查的前瞻性研究荟萃分析:乳腺癌检出率与间期癌率

Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening.
PubMed 文献 · Eur J Cancer · 2021-03-09

该研究系统纳入5项前瞻性非随机DBT人群筛查研究,比较DBT与乳腺X线摄影的乳腺癌检出率(CDR)和间期癌率(ICR)。汇总分析显示DBT显著提高CDR(差值3.15/1000,95%CI 2.53-3.77),但ICR差异无统计学意义(差值-0.15/1000,95%CI -0.59至0.29),提示可能存在过度检出但未证实。

要点

  • DBT筛查的汇总CDR为9.03/1000,显著高于乳腺X线摄影的5.95/1000。
  • DBT与乳腺X线摄影的汇总ICR差异无统计学意义(-0.15/1000,95%CI -0.59至0.29)。
  • CDR提高而ICR未显著降低,提示可能存在过度检出,但需个体数据荟萃分析验证。

核心结论

  • DBT相比乳腺X线摄影显著提高乳腺癌检出率,但间期癌率无显著差异。
  • 该结果可能提示部分过度检出,但未证实。

研究设计与样本

  • 研究-level荟萃分析,纳入5项前瞻性非随机DBT人群筛查研究。
  • 共分析129,969名DBT筛查参与者和227,882次乳腺X线摄影筛查。

主要发现

  • DBT汇总CDR为9.03/1000(95%CI 8.53-9.56),乳腺X线摄影为5.95/1000(95%CI 5.65-6.28)。
  • CDR汇总差值为3.15/1000(95%CI 2.53-3.77),在浸润性和原位癌检测中均明显。
  • DBT汇总ICR为1.56/1000(95%CI 1.22-2.00),乳腺X线摄影为1.75/1000(95%CI 1.46-2.11)。
  • ICR汇总差值为-0.15/1000(95%CI -0.59至0.29),敏感性分析未见实质改变。

临床怎么用

  • DBT可提高乳腺癌检出率,但临床解读需注意间期癌率未显著降低,可能存在过度检出。
  • 筛查项目决策应综合考量检出率提升与过度检出风险。

局限性

  • 纳入研究均为非随机设计,可能存在偏倚。
  • 缺乏个体参与者数据、随机对照试验及重复筛查轮次的累积检出与间期癌数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Breast cancer (BC) screening using digital breast tomosynthesis (DBT) has been shown to increase cancer detection compared with mammography; however, it is unknown whether DBT impacts interval cancer rate (ICR). METHODS: We systematically identified prospective DBT studies reporting data on screen-detected and interval BCs to perform a study-level meta-analysis of the comparative effect of DBT on ICR in population screening. Meta-analysis of cancer detection rate (CDR), ICR, and the differences between DBT and mammography in CDR and ICR pooled estimates, included random-effects. Sensitivity analysis examined whether study methods (imaging used, comparison group design, interval BC ascertainment) affected pooled estimates. RESULTS: Five eligible prospective (non-randomised) studies of DBT population screening reported on 129,969 DBT-screened participants and 227,882 mammography-only screens, including follow-up publications reporting interval BC data. Pooled CDR was 9.03/1000 (95% confidence interval [CI] 8.53-9.56) for DBT, and 5.95/1000 (95% CI 5.65-6.28) for mammography: the pooled difference in CDR was 3.15/1000 (95% CI 2.53-3.77), and was evident for the detection of invasive and in-situ malignancy. Pooled ICR was 1.56/1000 DBT screens (95% CI 1.22-2.00), and 1.75/1000 mammography screens (95% CI 1.46-2.11): the estimated pooled difference in ICR was -0.15/1000 (95% CI -0.59 to 0.29) and was not substantially altered in several sensitivity analyses. CONCLUSIONS: Meta-analysis shows consistent evidence that DBT significantly increased CDR compared with mammography screening; however, there was little difference between DBT and mammography in pooled ICR. This could suggest, but does not demonstrate, some over-detection. Meta-analysis using individual participant data, randomised trials and comparative studies quantifying cumulative detection and ICR over repeat DBT screen-rounds would provide valuable evidence to inform screening programs.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Houssami N, Zackrisson S, Blazek K, et al. Meta-analysis of prospective studies evaluating breast cancer detection and interval cancer rates for digital breast tomosynthesis versus mammography population screening. Eur J Cancer. 2021. PMID: 33706172. doi:10.1016/j.ejca.2021.01.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。